Tocqueville Asset Management’s aTyr Pharma ATYR Stock Holding History

Tocqueville Asset Management’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,150	Closed	-$21.3K	–	552
2023 Q1	$21.3K	Hold	10,150	–	–	﹤0.01%	527
2022 Q4	$22.2K	Hold	10,150	–	–	﹤0.01%	574
2022 Q3	$30K	Hold	10,150	–	–	﹤0.01%	592
2022 Q2	$29K	Hold	10,150	–	–	﹤0.01%	659
2022 Q1	$54K	Sell	10,150 -2,000	-16%	-$11.3K	﹤0.01%	701
2021 Q4	$91K	Sell	12,150 -2,700	-18%	-$22.5K	﹤0.01%	729
2021 Q3	$135K	Buy	+14,850	New	+$88.8K	﹤0.01%	710
2021 Q1	–	Sell	-21,700	Closed	-$84K	–	745
2020 Q4	$84K	Buy	+21,700	New	+$79.3K	﹤0.01%	694

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Tocqueville Asset Management's ATYR Position: Q2 2023 in Review

Tocqueville Asset Management sold out of aTyr Pharma (ATYR) in Q2 2023, closing a stake of 10,150 shares — an estimated $21.3K sold.

Tocqueville Asset Management first reported a position in ATYR in Q4 2020 and held it in 8 quarters. The position peaked at $135K in Q3 2021. 41 funds tracked by Wall St. Rank hold ATYR as of Q2 2023.

Tocqueville Asset Management reported no remaining aTyr Pharma position as of Q2 2023 after selling out during the quarter.
Tocqueville Asset Management sold 10,150 aTyr Pharma shares in Q2 2023, an estimated $21.3K.
Tocqueville Asset Management first reported a position in aTyr Pharma in Q4 2020 and held it in 8 quarters.
Tocqueville Asset Management's aTyr Pharma position peaked at $135K in Q3 2021.
41 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2023.

Based on Tocqueville Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.